Annual Conference of the European Association of Nuclear Medicine, Vienna Sept. 2023:
DOTA-MGS5, a novel cholecystokinin-2 receptortargeting peptide analogue for use in targeted
therapy, preclinical evaluation for clinical translation
T. Zavvar et al 
Novel Dual-Modality Imaging Agents Targeting the CCK2 Receptor by Chelator Scaffolding
G. Gariglio et al
Nuclear medicine research group IGDT-ART/ IGDT
